In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus

Abstract
Two new quinolones, NSFQ-104 and NSFQ-105, derivatives of ciprofloxacin and norfioxacin with a 4-(4-aminophenylsulphonyl)-1-piperazinyl at position 7 showed better in-vitro activity against strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus than ciprofloxacin or norfioxacin. Their in-vitro activity was enhanced at pH 5·5.

This publication has 0 references indexed in Scilit: